Preoperative Albumin Level Is Superior To Albumin-Globulin Ratio As A Predicting Indicator In Gastric Cancer Patients Who Underwent Curative Resection

References

• Fock KM. Review article: the epidemiology and prevention of gastric cancer. Aliment Pharmacol Ther. 2014;40(3 ):250–260. doi:10.1111/apt.2014.40.issue-324912650
   PubMed Web of Science ®Google Scholar
• Jung H, Lee HH, Song KY, Jeon HM, Park CH. Validation of the seventh edition of the American Joint Committee on Cancer TNM staging system for gastric cancer. Cancer. 2011;117(11 ):2371–2378. doi:10.1002/cncr.2577824048784
   PubMed Web of Science ®Google Scholar
• Marrelli D, Morgagni P, de Manzoni G, et al. Prognostic value of the 7th AJCC/UICC TNM classification of noncardia gastric cancer: analysis of a large series from specialized Western centers. Ann Surg. 2012;255(3 ):486–491. doi:10.1097/SLA.0b013e3182389b1a22167003
   PubMed Web of Science ®Google Scholar
• McMillan DC. The systemic inflammation-based glasgow prognostic score: a decade of experience in patients with cancer. Cancer Treat Rev. 2013;39(5 ):534–540. doi:10.1016/j.ctrv.2012.08.00322995477
   PubMed Web of Science ®Google Scholar
• Lee S, Oh SY, Kim SH, et al. Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy. BMC Cancer. 2013;13:350. doi:10.1186/1471-2407-13-35023876227
   PubMed Web of Science ®Google Scholar
• Yamanaka T, Matsumoto S, Teramukai S, Ishiwata R, Nagai Y, Fukushima M. The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer. Oncology. 2007;73(3–4 ):215–220. doi:10.1159/00012741218424885
   PubMed Web of Science ®Google Scholar
• Chen J, Zhou Y, Xu Y, Zhu HY, Shi YQ. Low pretreatment serum globulin may predict favorable prognosis for gastric cancer patients. Tumour Biol. 2016;37(3 ):3905–3911. doi:10.1007/s13277-015-3778-326476541
   PubMedGoogle Scholar
• Gupta D, Lis CG. Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr J. 2010;9:69. doi:10.1186/1475-2891-9-6921176210
   PubMed Web of Science ®Google Scholar
• Huang R, Ma Y, Holm R, Trope CG, Nesland JM, Suo Z. Sex hormone-binding globulin (SHBG) expression in ovarian carcinomas and its clinicopathological associations. PLoS One. 2013;8(12 ):e83238. doi:10.1371/journal.pone.008323824386165
   PubMed Web of Science ®Google Scholar
• Kristal AR, Schenk JM, Song Y, et al. Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial. Am J Epidemiol. 2008;168(12 ):1416–1424. doi:10.1093/aje/kwn27218945688
   PubMed Web of Science ®Google Scholar
• Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011;14(2 ):113–123. doi:10.1007/s10120-011-0042-421573742
   PubMed Web of Science ®Google Scholar
• Liu J, Chen S, Geng Q, et al. Prognostic value of pretreatment albumin-globulin ratio in predicting long-term mortality in gastric cancer patients who underwent D2 resection. Onco Targets Ther. 2017;10:2155–2162. doi:10.2147/OTT.S9928228458559
   PubMed Web of Science ®Google Scholar
• Deng J, Zhang R, Wu L, et al. Superiority of the ratio between negative and positive lymph nodes for predicting the prognosis for patients with gastric cancer. Ann Surg Oncol. 2015;22(4 ):1258–1266. doi:10.1245/s10434-014-4121-825319573
   PubMed Web of Science ®Google Scholar
• Huitzil-Melendez FD, Capanu M, O’Reilly EM, et al. Advanced hepatocellular carcinoma: which staging systems best predict prognosis? J Clin Oncol. 2010;28(17 ):2889–2895. doi:10.1200/JCO.2009.25.989520458042
   PubMed Web of Science ®Google Scholar
• Singh R, Mishra MK, Aggarwal H. Inflammation, immunity, and cancer. Mediators Inflamm. 2017;2017:6027305. doi:10.1155/2017/602730529234189
   PubMed Web of Science ®Google Scholar
• Sonnenschein C, Soto AM, Michaelson CL. Human serum albumin shares the properties of estrocolyone-I, the inhibitor of the proliferation of estrogen-target cells. J Steroid Biochem Mol Biol. 1996;59(2 ):147–154. doi:10.1016/S0960-0760(96)00112-49010329
   PubMed Web of Science ®Google Scholar
• Lien YC, Hsieh CC, Wu YC, et al. Preoperative serum albumin level is a prognostic indicator for adenocarcinoma of the gastric cardia. J Gastrointest Surg. 2004;8(8 ):1041–1048. doi:10.1016/j.gassur.2004.09.03315585392
   PubMed Web of Science ®Google Scholar
• Alkan A, Koksoy EB, Utkan G. Albumin to globulin ratio, a predictor or a misleader? Ann Oncol. 2015;26(2 ):443–444. doi:10.1093/annonc/mdu55425467014
   PubMed Web of Science ®Google Scholar
• Pfensig C, Dominik A, Borufka L, Hinz M, Stange J, Eggert M. A new application for albumin dialysis in extracorporeal organ support: characterization of a putative interaction between human albumin and proinflammatory cytokines IL-6 and TNFalpha. Artif Organs. 2016;40(4 ):397–402. doi:10.1111/aor.1255726365493
   PubMed Web of Science ®Google Scholar
• Anraku M, Shintomo R, Taguchi K, et al. Amino acids of importance for the antioxidant activity of human serum albumin as revealed by recombinant mutants and genetic variants. Life Sci. 2015;134:36–41. doi:10.1016/j.lfs.2015.05.01026032253
   PubMed Web of Science ®Google Scholar
• Rehman MT, Khan AU. Understanding the interaction between human serum albumin and anti-bacterial/anti-cancer compounds. Curr Pharm Des. 2015;21(14 ):1785–1799. doi:10.2174/138161282166615030416120125738491
   PubMed Web of Science ®Google Scholar
• Onate-Ocana LF, Aiello-Crocifoglio V, Gallardo-Rincon D, et al. Serum albumin as a significant prognostic factor for patients with gastric carcinoma. Ann Surg Oncol. 2007;14(2 ):381–389. doi:10.1245/s10434-006-9093-x17160496
   PubMed Web of Science ®Google Scholar
• Alici S, Kaya S, Izmirli M, et al. Analysis of survival factors in patients with advanced-stage gastric adenocarcinoma. Med Sci Monit. 2006;12(5 ):Cr221–Cr229.16641880
   PubMed Web of Science ®Google Scholar
• Chang WJ, Du Y, Zhao X, Ma LY, Cao GW. Inflammation-related factors predicting prognosis of gastric cancer. World J Gastroenterol. 2014;20(16 ):4586–4596. doi:10.3748/wjg.v20.i16.458624782611
   PubMed Web of Science ®Google Scholar
• Toiyama Y, Yasuda H, Ohi M, et al. Clinical impact of preoperative albumin to globulin ratio in gastric cancer patients with curative intent. Am J Surg. 2017;213(1 ):120–126. doi:10.1016/j.amjsurg.2016.05.01227814784
   PubMed Web of Science ®Google Scholar
• Xue F, Lin F, Yin M, et al. Preoperative albumin/globulin ratio is a potential prognosis predicting biomarker in patients with resectable gastric cancer. Turk J Gastroenterol. 2017;28(6 ):439–445. doi:10.5152/tjg29086711
   PubMed Web of Science ®Google Scholar
• Shimizu T, Ishizuka M, Shibuya N, et al. Preoperative globulin-to-albumin ratio predicts outcome after curative resection in patients with gastric cancer. Ann Gastroenterol Surg. 2018;2(5 ):367–375. doi:10.1002/ags3.2018.2.issue-530238078
   PubMed Web of Science ®Google Scholar
• Mao MJ, Wei XL, Sheng H, et al. Clinical significance of preoperative albumin and globulin ratio in patients with gastric cancer undergoing treatment. Biomed Res Int. 2017;2017:3083267. doi:10.1155/2017/308326728424782
   PubMed Web of Science ®Google Scholar
• Bozkaya Y, Erdem GU, Demirci NS, et al. Prognostic importance of the albumin to globulin ratio in metastatic gastric cancer patients. Curr Med Res Opin. 2019;35(2 ):275–282. doi:10.1080/03007995.2018.147968329785861
   PubMed Web of Science ®Google Scholar